Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Trends in US Melanoma Incidence and Mortality

JAMA Dermatol; ePub 2016 Dec 21; Glazer, et al

The overall burden of disease for melanoma is increasing, according to a study comparing incidence in 2016 and 2009.

Investigators looked at the number of invasive melanomas reported for both years. They then calculated the lifetime risk of developing a melanoma, and determined the annual percentage growth rate over 7 years. Among the results:

  • More than 76,000 Americans were estimated to be diagnosed with invasive melanoma in 2016.
  • Raw incidence rates per 100,000 population rose to 23.6 from 22.2.
  • The current lifetime risk of an American developing invasive melanoma is 1 in 54, vs 1 in 58 in 2009.
  • In situ melanoma incidence has risen to 1 in 58 from 1 in 78.
  • The lifetime risk for being diagnosed with invasive or in situ melanoma is now 1 in 28.
  • It is estimated that more than 10,000 Americans died from melanoma in 2016, vs ~8,600 in 2009.

Citation:

Glazer A, Winkelmann R, Farberg A, Rigel D. Analysis of trends in US melanoma incidence and mortality. [Published online ahead of print December 21, 2016]. JAMA Dermatol. doi:10.1001/jamadermatol.2016.4512.